SFG
DGX icon

Strive Financial Group’s Quest Diagnostics DGX Stock Holding History

Strive Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.1K Sell
279
-141
-34% -$27.7K 0.03% 255
2026
Q1 		$82K Sell
420
-86
-17% -$16.7K 0.04% 176
2025
Q4 		$87.8K Buy
+506
New +$92.1K 0.05% 176

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Strive Financial Group's DGX Position: Q2 2026 in Review

Strive Financial Group reduced its Quest Diagnostics (DGX) stake by 34% in Q2 2026, selling an estimated $27.7K and leaving 279 shares worth $59.1K. The position accounts for 0.03% of the portfolio, ranked #255.

Strive Financial Group first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. The position peaked at $87.8K in Q4 2025. 1,103 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Strive Financial Group held 279 shares of Quest Diagnostics worth $59.1K as of Q2 2026.
  • Strive Financial Group sold 141 Quest Diagnostics shares in Q2 2026, an estimated $27.7K.
  • Quest Diagnostics made up 0.03% of Strive Financial Group's portfolio in Q2 2026, its #255 holding.
  • Strive Financial Group first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • Strive Financial Group's Quest Diagnostics position peaked at $87.8K in Q4 2025.
  • 1,103 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.